Skip to main content
To the Editor: We report on a 22-year-old man who has a 9-year history of glue-sniffing that evolved into a full-blown picture of psychological dependency that was characterized by craving and tolerance, which was subsequently followed by agitation, irritability, and physical struggle. It gradually ended with period of low mood, lack of motivation, and social withdrawal. The disturbance was punctuated by episodes of florid psychosis during intoxication, which included visual hallucination and disorganized behavior. After 6 years of chronic glue-sniffing, there was an insidious onset of bilateral, low-frequency intention tremors involving the upper limbs that gradually worsened and was accompanied by unstable gait, stuttering of speech, and blurring of vision. There was no history to suggest seizure disorder or any infection of the central nervous system. There was a 1-year delay before presentation to medical services due to shame and guilt feelings about coming out of the house because of the physical problems. Mental state examination (MSE) revealed presence of scanning speech and impairment of abstract thinking. He scored 26/30 on Mini-Mental State Exam (MMSE). He had bilateral, persistent, horizontal, pendular nystagmus, and bilateral intention tremors of the hands, broad-based gait, past pointing and dysdiadokinesia of the upper limbs, which were more prominent on the right side. Further examination revealed optic atrophy of the right eye, but sensorimotor functions were normal, and muscle wasting was absent.
Blood and urine biochemistry that included measurements of serum lactate and ceruloplasmin were negative, as was the screening for other commonly abused substances. Magnetic resonance imaging (MRI) of the brain demonstrated extensive increased T2 signal in the white matter extending from the centrum semiovale, down the posterior limb of the internal capsule, and through the anterolateral pons, as well as the white matter of the cerebellar hemispheres (Figure 1). Low signal is seen in the deep gray-matter structures, particularly involving the thalami, globus pallidi, and dentate nuclei, as well as the red nuclei and substantia nigra (Figure 2). Widespread cerebral and cerebellar volume loss is also present, with marked thinning of the corpus callosum, without T2 signal change.
FIGURE 1. There was extensive increased T2 signal in the white matter, extending from the centrum semiovale, down the posterior limb of the internal capsule, and through the anterolateral pons, as well as the white matter of the cerebellar hemispheres.
FIGURE 2. Low signal is seen in the deep gray-matter structures, particularly involving the thalami, globus pallidi, and dentate nuclei, as well as the red nuclei and substantia nigra.
T: thalamus; SN: substantia nigra; RN: red nuclei; DN: dentate nuclei; GP: globus pallidus.
Treatment was initiated with propranolol 40 mg bid. This was discontinued after 3 months because of lack of efficacy, and he was started on treatment with amantadine 100 mg nightly, primidone 250 mg nightly, and supplemented with thiamine. Despite 6 months of the above treatments, there has been no improvement. He continues to sniff glue, albeit at a much lower frequency and amount.
Peripheral neuropathy, cerebellar dysfunction, cranial nerve damage, cortical atrophy, encephalopathy, and dementia have all been attributed to result from prolonged and heavy exposure to inhalants.1,2 N-hexane and toluene adhere to lipid-laden myelin sheaths and neuronal membranes to start the demyelinating process.3 Cerebellar damage due to toluene was first reported three decades ago, and it commonly presents with tremors and ataxia, which correlate to the extent of sulci enlargement.1

References

1.
Fornazzari L, Wilkinson DA, Kapur BM, et al.: Cerebellar, cortical, and functional impairment in toluene abusers. Acta Neurol Scand 1983; 67:319–329
2.
Maruff P, Burns CB, Tyler P, et al.: Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain 1998; 121:1903–1917
3.
Lolin Y: Chronic neurological toxicity associated with exposure to volatile substances. Hum Toxicol 1989; 8:293–300

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E42 - E43
PubMed: 23686059

History

Published online: 1 April 2013
Published in print: Spring 2013

Authors

Details

Mohd Fadzli Mohd Isa, M.B.B.S.
Norzaini Rose Mohd Zain, M.Med., F.R.C.R.
Francesco Gaillard, M.Med., FRANZCR
Kok-Yoon Chee, M.D., M.Med.
Dept. of Psychiatry and Mental Health, Hospital Kuala Lumpur, Malaysia
Dept. of Diagnostic Imaging, Hospital Kuala Lumpur, Malaysia
Dept. of Radiology, Royal Melbourne Hospital, Australia

Notes

Correspondence: Dr. Kok-Yoon Chee; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share